The introduction of off-patent semaglutide is predicted to revolutionize the landscape of diabetes. Previously restricted to expensive formulations, this life-changing GLP-1 medication is now available to a larger patient population, potentially boosting health and lowering the cost for numerous who live with the disease. This shift signifies a key